A government campaign to give boys Gardasil, a cervical cancer vaccine that protects against human papillomavirus, would be no more effective in reducing HPV-related diseases and cost much more than a vaccination campaign directed at girls, Harvard University researchers concluded. The findings come as the FDA considers allowing boys to receive Gardasil, made by Merck & Co.

Related Summaries